BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 23273263)

  • 1. Prognostic value of stromal and epithelial periostin expression in human prostate cancer: correlation with clinical pathological features and the risk of biochemical relapse or death.
    Nuzzo PV; Rubagotti A; Zinoli L; Ricci F; Salvi S; Boccardo S; Boccardo F
    BMC Cancer; 2012 Dec; 12():625. PubMed ID: 23273263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel prostate Cancer-Stroma Sphere (CSS) model for In Vitro tumor microenvironment studies.
    Rakhmatullina AR; Zolotykh MA; Filina YV; Mingaleeva RN; Sagdeeva AR; Boulygina EA; Gafurbaeva DU; Bulatov ER; Rizvanov AA; Miftakhova RR
    Transl Oncol; 2024 Jun; 44():101930. PubMed ID: 38520912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microfluidic-based human prostate-cancer-on-chip.
    Jiang L; Khawaja H; Tahsin S; Clarkson TA; Miranti CK; Zohar Y
    Front Bioeng Biotechnol; 2024; 12():1302223. PubMed ID: 38322789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current evidence regarding the cellular mechanisms associated with cancer progression due to cardiovascular diseases.
    Attachaipanich T; Chattipakorn SC; Chattipakorn N
    J Transl Med; 2024 Jan; 22(1):105. PubMed ID: 38279150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.
    Samaržija I
    Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38255186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct mesenchymal cell states mediate prostate cancer progression.
    Pakula H; Omar M; Carelli R; Pederzoli F; Fanelli GN; Pannellini T; Socciarelli F; Van Emmenis L; Rodrigues S; Fidalgo-Ribeiro C; Nuzzo PV; Brady NJ; Dinalankara W; Jere M; Valencia I; Saladino C; Stone J; Unkenholz C; Garner R; Alexanderani MK; Khani F; de Almeida FN; Abate-Shen C; Greenblatt MB; Rickman DS; Barbieri CE; Robinson BD; Marchionni L; Loda M
    Nat Commun; 2024 Jan; 15(1):363. PubMed ID: 38191471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct mesenchymal cell states mediate prostate cancer progression.
    Pakula H; Omar M; Carelli R; Pederzoli F; Fanelli GN; Pannellini T; Van Emmenis L; Rodrigues S; Fidalgo-Ribeiro C; Nuzzo PV; Brady NJ; Jere M; Unkenholz C; Alexanderani MK; Khani F; de Almeida FN; Abate-Shen C; Greenblatt MB; Rickman DS; Barbieri CE; Robinson BD; Marchionni L; Loda M
    bioRxiv; 2023 Apr; ():. PubMed ID: 37034687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Periostin: biology and function in cancer.
    Dorafshan S; Razmi M; Safaei S; Gentilin E; Madjd Z; Ghods R
    Cancer Cell Int; 2022 Oct; 22(1):315. PubMed ID: 36224629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor splice variant 7 detected by immunohistochemical is an independent poor prognostic marker in men receiving adjuvant androgen-deprivation therapy after radical prostatectomy.
    Ouyang W; Zhang Y; Long G; Sun G; Liu M; Li F; Yang C; Zeng X; Yang J; Yu X; Wang Z; Liu Z; Guan W; Hu Z; Wang S; Liu X; Li H; Xu H; Ye Z
    Biomark Res; 2021 Mar; 9(1):23. PubMed ID: 33789757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The research status and prospect of Periostin in chronic kidney disease.
    Jia YY; Yu Y; Li HJ
    Ren Fail; 2020 Nov; 42(1):1166-1172. PubMed ID: 33241962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer.
    Cattrini C; Barboro P; Rubagotti A; Zinoli L; Zanardi E; Capaia M; Boccardo F
    Transl Oncol; 2020 Jul; 13(7):100789. PubMed ID: 32416542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.
    Zhu Y; Weiss T; Zhang Q; Sun R; Wang B; Yi X; Wu Z; Gao H; Cai X; Ruan G; Zhu T; Xu C; Lou S; Yu X; Gillet L; Blattmann P; Saba K; Fankhauser CD; Schmid MB; Rutishauser D; Ljubicic J; Christiansen A; Fritz C; Rupp NJ; Poyet C; Rushing E; Weller M; Roth P; Haralambieva E; Hofer S; Chen C; Jochum W; Gao X; Teng X; Chen L; Zhong Q; Wild PJ; Aebersold R; Guo T
    Mol Oncol; 2019 Nov; 13(11):2305-2328. PubMed ID: 31495056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin: A Matricellular Protein With Multiple Functions in Cancer Development and Progression.
    González-González L; Alonso J
    Front Oncol; 2018; 8():225. PubMed ID: 29946533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneous Periostin Expression in Different Histological Variants of Papillary Thyroid Carcinoma.
    Giusca SE; Amalinei C; Lozneanu L; Ciobanu Apostol D; Andriescu EC; Scripcariu A; Balan R; Avadanei ER; Căruntu ID
    Biomed Res Int; 2017; 2017():8701386. PubMed ID: 29435461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    Kim GE; Lee JS; Park MH; Yoon JH
    PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.
    Li H; Wang Z; Xiao W; Yan L; Guan W; Hu Z; Wu L; Huang Q; Wang J; Xu H; Zhang X; Ye Z
    Mod Pathol; 2018 Jan; 31(1):198-208. PubMed ID: 29076496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between periostin and epithelial-mesenchymal transition in esophageal squamous cell carcinoma and its clinical significance.
    Lv YJ; Wang W; Ji CS; Jia ; Xie MR; Hu B
    Oncol Lett; 2017 Jul; 14(1):376-382. PubMed ID: 28693179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of serum periostin in patients with non-small cell lung cancer.
    Xu CH; Wang W; Lin Y; Qian LH; Zhang XW; Wang QB; Yu LK
    Oncotarget; 2017 Mar; 8(12):18746-18753. PubMed ID: 27816968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of stromal and epithelial periostin expression in human breast cancer: correlation with clinical pathological features and mortality outcome.
    Nuzzo PV; Rubagotti A; Zinoli L; Salvi S; Boccardo S; Boccardo F
    BMC Cancer; 2016 Feb; 16():95. PubMed ID: 26872609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNA-directed epigenetic silencing of Periostin inhibits cell motility.
    Lister NC; Clemson M; Morris KV
    R Soc Open Sci; 2015 Jun; 2(6):140545. PubMed ID: 26543579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.